5th Jul 2018 14:08
LONDON (Alliance News) - Sinclair Pharma PLC on Thursday confirmed that it is in talks with China Grand Enterprises Inc regarding a possible offer for the company.
The pharmaceutical company, noting the recent share price movement, said that it was approached by China Grand and its affiliate Huadong Medicine Co Ltd. It, however, added that there can be no certainty that an offer will be made.
The stock was trading 25% higher on Thursday at 22.85 pence per share.
Beijing-based China Grand Enterprises is an investment company focused on pharmaceuticals and healthcare, commodities trading, real estate investment, financial service and other sectors.
Related Shares:
Sinclair Pharma